Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study

Fig. 6

PD-1-positive lymphocytes and PEM treatment. PD-1-positive peripheral blood cells of long-term PEM treatment group (PEM ≥ 17 cycles), short or intermediate group (PEM ≤ 16 cycles), and control group (chemo-naive). The percentage of PD-1-positive lymphocytes was significantly high in the long-term PEM treatment group. PEM = Pemetrexed, PD-1 = programmed cell death 1. **: P < 0.05 (Unpaired t-test) *: P < 0.1 (Unpaired t-test)

Back to article page